Influence of a six month endurance exercise program on the immune function of prostate cancer patients undergoing Antiandrogen- or Chemotherapy: design and rationale of the ProImmu...

by Zimmer, Philipp, Jäger, Elke, Bloch, Wilhelm, Zopf, Eva Maria, Baumann, Freerk T
Published 2013

Phase I study of everolimus and mitomycin C for patients with metastatic esophagogastric adenocarcinoma

by Werner, Dominique, Atmaca, Akin, Pauligk, Claudia, Pustowka, Anette, Jäger, Elke, Al-Batran, Salah-Eddin
Published 2013

The prognostic impact of epidermal growth factor receptor in patients with metastatic gastric cancer

by Atmaca, Akin, Werner, Dominique, Pauligk, Claudia, Steinmetz, Kristina, Wirtz, Ralph, Altmannsberger, Hans-Michael, Jäger, Elke, Al-Batran, Salah-Eddin
Published 2012

SNAI2/SLUG and estrogen receptor mRNA expression are inversely correlated and prognostic of patient outcome in metastatic non-small cell lung cancer

by Atmaca, Akin, Wirtz, Ralph W, Werner, Dominique, Steinmetz, Kristina, Claas, Silke, Brueckl, Wolfgang M, Jäger, Elke, Al-Batran, Salah-Eddin
Published 2015

Identification of Ny-Eso-1 Epitopes Presented by Human Histocompatibility Antigen (Hla)-Drb4*0101–0103 and Recognized by Cd4+T Lymphocytes of Patients with Ny-Eso-1–Expressing Mela...

by Jäger, Elke, Jäger, Dirk, Karbach, Julia, Chen, Yao-Tseng, Ritter, Gerd, Nagata, Yasuhiro, Gnjatic, Sacha, Stockert, Elisabeth, Arand, Michael, Old, Lloyd J., Knuth, Alexander
Published 2000

A Survey of the Humoral Immune Response of Cancer Patients to a Panel of Human Tumor Antigens

by Stockert, Elisabeth, Jäger, Elke, Chen, Yao-Tseng, Scanlan, Matthew J., Gout, Ivan, Karbach, Julia, Arand, Michael, Knuth, Alexander, Old, Lloyd J.
Published 1998

Simultaneous Humoral and Cellular Immune Response against Cancer–Testis Antigen NY-ESO-1: Definition of Human Histocompatibility Leukocyte Antigen (HLA)-A2–binding Peptide Epitopes...

by Jäger, Elke, Chen, Yao-Tseng, Drijfhout, Jan W., Karbach, Julia, Ringhoffer, Mark, Jäger, Dirk, Arand, Michael, Wada, Hisashi, Noguchi, Yuji, Stockert, Elisabeth, Old, Lloyd J., Knuth, Alexander
Published 1998

Regulation of circulating endocannabinoids associated with cancer and metastases in mice and humans

by Sailler, Sebastian, Schmitz, Katja, Jäger, Elke, Ferreiros, Nerea, Wicker, Sabine, Zschiebsch, Katja, Pickert, Geethanjali, Geisslinger, Gerd, Walter, Carmen, Tegeder, Irmgard, Lötsch, Jörn
Published 2014

Expression of TAAs in glioblastoma and expansion of anti-TAA -reactive T cells

by Dodoo, Ernest, zhenjiang, Liu, Jiri , Bartek, Persson, Oscar, Meng, Qingda, Poiret, Thomas, Rane, Lalit, Illies, Christopher, Karbach, Julia, Jäger, Elke, Maeurer, Markus
Published 2014

Phase I clinical study of the recombinant antibody toxin scFv(FRP5)-ETA specific for the ErbB2/HER2 receptor in patients with advanced solid malignomas

by von Minckwitz, Gunter, Harder, Sebastian, Hövelmann, Sascha, Jäger, Elke, Al-Batran, Salah-Eddin, Loibl, Sibylle, Atmaca, Akin, Cimpoiasu, Christian, Neumann, Antje, Abera, Aklil, Knuth, Alexander, Kaufmann, Manfred, Jäger, Dirk, Maurer, Alexander B, Wels, Winfried S
Published 2005

Correction: Phase I clinical study of the recombinant antibody-toxin scFv(FRP5)-ETA specific for the ErbB2/HER2 receptor in patients with advanced solid malignomas

by von Minckwitz, Gunter, Harder, Sebastian, Hövelmann, Sascha, Jäger, Elke, Al-Batran, Salah-Eddin, Loibl, Sibylle, Atmaca, Akin, Cimpoiasu, Christian, Neumann, Antje, Abera, Aklil, Knuth, Alexander, Kaufmann, Manfred, Jäger, Dirk, Maurer, Alexander B, Wels, Winfried S
Published 2006

Local immunotherapy with ONCOS-102 shapes harmful tumor associated CD68+ macrophages to become beneficial cells that correlate with increased overall survival

by Pesonen, Sari, Lundin, Johan, Linder, Nina, Turkki, Riku, Ristimäki, Ari, Joensuu, Timo, Kairemo, Kalevi, Partanen, Kaarina, Alanko, Tuomo, Jäger, Elke, Karbach, Julia, Wahle, Claudia, Hemminki, Akseli, Backman, Charlotta, von Euler, Mikael, Hakonen, Tiina, Ranki, Tuuli, Vuolanto, Antti, Jäderberg, Magnus, Zamarin, Dmitry
Published 2015

Phase I study with ONCOS-102 for the treatment of solid tumors – an evaluation of clinical response and exploratory analyses of immune markers

by Ranki, Tuuli, Pesonen, Sari, Hemminki, Akseli, Partanen, Kaarina, Kairemo, Kalevi, Alanko, Tuomo, Lundin, Johan, Linder, Nina, Turkki, Riku, Ristimäki, Ari, Jäger, Elke, Karbach, Julia, Wahle, Claudia, Kankainen, Matti, Backman, Charlotta, von Euler, Mikael, Haavisto, Elina, Hakonen, Tiina, Heiskanen, Raita, Jaderberg, Magnus, Juhila, Juuso, Priha, Petri, Suoranta, Laura, Vassilev, Lotta, Vuolanto, Antti, Joensuu, Timo
Published 2016

Gene expression analysis of tumors demonstrates an induction of Th1 type immune response following intratumoral administration of ONCOS-102 in refractory solid tumor patients

by Majumder, Mamun, Kumar, Ashwini, Heckman, Caroline, Kankainen, Matti, Pesonen, Sari, Jäger , Elke, Karbach , Julia, Joensuu, Timo, Kairemo, Kalevi, Partanen, Kaarina, Alanko, Tuomo, Hemminki, Akseli, Backman, Charlotta, Dienel, Kasper, von Euler, Mikael, Hakonen, Tiina, Juhila, Juuso, Ranki, Tuuli, Vassilev, Lotta, Vuolanto, Antti, Jaderberg, Magnus
Published 2014

Local treatment of a pleural mesothelioma tumor with ONCOS-102 induces a systemic antitumor CD8+ T-cell response, prominent infiltration of CD8+ lymphocytes and Th1 type polarizati...

by Ranki, Tuuli, Joensuu, Timo, Jäger, Elke, Karbach, Julia, Wahle, Claudia, Kairemo, Kalevi, Alanko, Tuomo, Partanen, Kaarina, Turkki, Riku, Linder, Nina, Lundin, Johan, Ristimäki, Ari, Kankainen, Matti, Hemminki, Akseli, Backman, Charlotta, Dienel, Kasper, von Euler, Mikael, Haavisto, Elina, Hakonen, Tiina, Juhila, Juuso, Jaderberg, Magnus, Priha, Petri, Vassilev, Lotta, Vuolanto, Antti, Pesonen, Sari
Published 2014